TI
CRL icon

Trexquant Investment’s Charles River Laboratories CRL Stock Holding History

Trexquant Investment’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,345
Closed -$3.34M – 1631
2025
Q3 		$3.34M Sell
21,345
-39,970
-65% -$6.35M 0.03% 706
2025
Q2 		$9.3M Buy
61,315
+39,644
+183% +$5.29M 0.1% 273
2025
Q1 		$3.26M Sell
21,671
-78,606
-78% -$13.2M 0.04% 681
2024
Q4 		$18.5M Buy
100,277
+81,714
+440% +$15.7M 0.22% 98
2024
Q3 		$3.66M Buy
18,563
+10,440
+129% +$2.17M 0.05% 598
2024
Q2 		$1.68M Buy
+8,123
New +$1.84M 0.03% 813
2023
Q4 		– Sell
-20,942
Closed -$4.1M – 1480
2023
Q3 		$4.1M Buy
+20,942
New +$4.3M 0.1% 278
2023
Q2 		– Sell
-25,233
Closed -$5.09M – 1496
2023
Q1 		$5.09M Buy
+25,233
New +$5.72M 0.14% 183
2022
Q3 		– Sell
-2,492
Closed -$533K – 1433
2022
Q2 		$533K Sell
2,492
-15,019
-86% -$3.67M 0.02% 792
2022
Q1 		$4.97M Buy
17,511
+16,300
+1,346% +$5.03M 0.23% 101
2021
Q4 		$456K Buy
+1,211
New +$470K 0.03% 695
2020
Q3 		– Sell
-4,132
Closed -$720K – 1243
2020
Q2 		$720K Buy
4,132
+2,539
+159% +$405K 0.05% 527
2020
Q1 		$201K Buy
+1,593
New +$239K 0.01% 974
2019
Q3 		– Sell
-8,307
Closed -$1.18M – 902
2019
Q2 		$1.18M Buy
8,307
+1,406
+20% +$191K 0.11% 276
2019
Q1 		$1M Sell
6,901
-11,044
-62% -$1.45M 0.07% 398
2018
Q4 		$2.03M Buy
+17,945
New +$2.25M 0.13% 237
2018
Q3 		– Sell
-9,013
Closed -$1.01M – 977
2018
Q2 		$1.01M Buy
9,013
+4,109
+84% +$444K 0.07% 370
2018
Q1 		$523K Buy
+4,904
New +$529K 0.04% 620
2017
Q1 		– Sell
-9,381
Closed -$715K – 1114
2016
Q4 		$715K Buy
+9,381
New +$712K 0.11% 297
2015
Q4 		– Sell
-22,300
Closed -$1.42M – 1058
2015
Q3 		$1.42M Buy
+22,300
New +$1.6M 0.12% 281

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Trexquant Investment's CRL Position: Q4 2025 in Review

Trexquant Investment sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 21,345 shares — an estimated $3.34M sold.

Trexquant Investment first reported a position in CRL in Q3 2015 and held it in 20 quarters. The position peaked at $18.5M in Q4 2024. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Trexquant Investment reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 21,345 Charles River Laboratories shares in Q4 2025, an estimated $3.34M.
  • Trexquant Investment first reported a position in Charles River Laboratories in Q3 2015 and held it in 20 quarters.
  • Trexquant Investment's Charles River Laboratories position peaked at $18.5M in Q4 2024.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.